U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07430215) titled 'CLABSI Incidence in ICU' on Feb. 18.
Brief Summary: In a worldwide, one-day, prospective point prevalence study, a prevalence of 15.1% for hospital-acquired central line-associated bloodstream infections (HA-CLABSI) was determined in 13,796 patients across 1,265 intensive care units in 75 countries (Vincent et al. 2009). According to reference data from the National Reference Center for Surveillance of Nosocomial Infections, an average of 1.2 HA-CLABSI episodes per 1,000 central venous catheter days occurred in German intensive care units between 2020 and 2024 (NRZ 2025). Since the mean length of stay for the observed patients was 4...